Understanding the effectiveness of mouth tape and its association with respiratory events in a capsule hotel type sleeping facility

Understanding the effectiveness of mouth tape and its association with respiratory events in a capsule hotel type sleeping facility - Understanding the effectiveness of mouth tape and its association with respiratory events in a capsule hotel type sleeping facility

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000059554

Enrollment

120

Registered

2025-10-30

Start date

2025-10-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sleeping with mouth tape Sleeping with mouth tape- &gt

Sleeping without mouth tape Sleeping without mouth tape -&gt

Sleeping with mouth tape

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ?Subjects who are over 20 years old and under 60 years old at the time of obtaining consent ?Subjects staying overnight for 1 or 2days during the study period ?Subjects who fully understood and provided written consent after receiving an explanation about this study before participating in the study ?Subjects who agree to keep the difference in their bedtime and wake-up time between the first and second nights within one hour, as much as possible (applicable to two-night participants)

Exclusion criteria

Exclusion criteria: ?Subjects whose BMI is below 18.5 or above 30.0 ?Subjects who wish to carry out the following items on the day of the test and during the test period-> Drinking alcohol, Excessive exercise, Caffeine intake after 6pm ?Subjects who regularly use some kind of medicine or treatment device?Subjects who are unable to put on and take offthis product voluntarily (such as those with dementia) ?Subjects who have used the test product and felt any abnormality ?Subjects whose sleep duration is extremely short (less than 6 hours) (for single-night participants). ?Subjects with a history of illness or treatment related to symptoms of nasal congestion or respiratory symptoms (within the past year) ?Subjects judged to be inappropriate by the person in charge of the research

Design outcomes

Primary

Measure	Time frame
Sleep measurement data	—

Secondary

Measure	Time frame
Observation of participant state/behavior using an infrared camera	—

Countries

Japan

Contacts

Public ContactKeita Inoue

Kobayashi Pharmaceutical Co., Ltd. R&D Headquarters Personal and Home Care Development Department Wellness Care Development Group

ke.inoue@kobayashi.co.jp080-4108-7549

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026